Therapeutic Options in Chronic Weight Management
Playback speed
10 seconds
Weight Wellness for the PCP: The Next Generation of Anti-Obesity Medications
2,372 views
April 2, 2024
Disclaimer: On November 8, 2023 the FDA approved Zepbound (tirzepatide) injection for chronic weight management ...
read more ↘ in adults with obesity (body mass index of 30 kilograms per square meter (kg/ m2) or greater) or overweight (body mass index of 27 kg/m2 or greater) with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in addition to a reduced calorie diet and increased physical activity.
↖ read less
read more ↘ in adults with obesity (body mass index of 30 kilograms per square meter (kg/ m2) or greater) or overweight (body mass index of 27 kg/m2 or greater) with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in addition to a reduced calorie diet and increased physical activity.
↖ read less
Comments 3
Login to view comments.
Click here to Login